YOUR LAB NEXT DOOR, WHEREVER YOU ARE CONTACT US SO MUCH MORE THAN JUST MEDICINAL CHEMISTRY SERVICES A team that is led by a passion for chemistry, Organix has a reputation for devising elegant solutions to complex challenges. PHD-LED PARTNERSHIPS Our team of PhD chemists synthesize, invent, create and deliver compounds in an efficient and effective manner for the benefit of our clients. POWERFUL COLLABORATIONS; ELEGANT SOLUTIONS Our team becomes part of your Research Group. We provide regular meetings, detailed reports and a flexible relationship with an immediate response to your changing needs. LEARN MORE STATE OF THE ART FACILITY Organix is located in a custom built building designed for specialized use as an organic chemistry facility. In 2018, we initiated a large-scale build out that added more instrumentation and large scale reactors. Organix, Inc. provides organic synthesis services across all areas of organic chemistry. Our chemistry specialists partner with Biotech & Pharmaceutical industry and Government clients to solve challenges at the forefront of complex chemistry. Organix coronavirus-covid-19 update: Organix is open and proud to support the bio-pharma industry during this critical time. ORGANIX 240 Salem Street Woburn, MA 01801 email: organix@organixinc.com phone: 781-932-4142 We use cookies to provide you with a great experience and to help our website run effectively. By using this website, you agree to our use of cookies.

RESEARCH Organix has a well-established federally funded internal research program. This program is being supported by the National Institutes of Health. GRANTS Organix was awarded a Fast Track SBIR grant to design compounds to inhibit breast cancer metastasis . Dr. Anu Mahadevan is the Principal Investigator on this two year SBIR grant R44CA206723 entitled "Targeting breast cancer metastasis with Id1" awarded by National Cancer Institute (NCI). Organix is collaborating with scientists at CPMC Research Institute in this program. Dr. Anu Mahadevan has received an award from Oregon Health & Science University to design and synthesize prospective inhibitors of the vesicular monoamine uptake mechanism, VMAT2. The goal of this grant is to discover potential medications for methamphetamine addiction. Organix is collaborating with scientists at OHSU in these studies. Organix has been awarded an NIH contract for CRO Support for NCATS Medicinal Chemistry for Lead Optimization (N01TR-19-2007). ORGANIX 240 Salem Street Woburn, MA 01801 email: organix@organixinc.com phone: 781-932-4142 We use cookies to provide you with a great experience and to help our website run effectively. By using this website, you agree to our use of cookies.